Kindred biosciences, inc. (KIN)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
ASSETS
Current assets:
Cash and cash equivalents

13,960

15,986

39,164

31,980

68,598

56,302

69,984

85,430

44,496

34,813

43,626

36,853

19,866

6,687

13,311

16,043

9,611

19,992

4,539

14,822

5,418

12,969

8,324

9,338

36,513

65,329

Short-term investments

39,493

55,723

48,279

47,601

27,390

17,630

21,642

24,500

26,328

46,207

42,678

36,692

45,272

50,068

47,168

45,110

58,962

53,051

-

-

-

-

-

-

-

-

Accounts receivable

244

923

801

937

275

903

242

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

824

4,218

4,223

4,358

4,525

3,570

2,521

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

-

492

2,118

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

88,058

-

-

-

0

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

79,047

74,914

89,171

-

98,103

103,100

24,015

-

Prepaid expenses and other

3,893

2,495

1,528

1,869

1,924

1,664

1,463

1,541

1,383

797

911

1,235

1,156

1,282

887

899

862

712

449

443

591

477

688

532

565

148

Total current assets

58,414

79,345

93,995

86,745

102,712

80,069

95,852

111,471

72,207

81,817

87,215

75,272

68,412

58,037

61,366

62,052

69,435

73,755

84,035

90,179

95,180

101,504

107,115

112,970

61,093

65,477

Property and equipment, net

30,292

29,777

29,574

28,576

28,136

26,343

17,483

10,621

7,907

7,457

6,382

2,553

2,585

2,441

1,796

1,734

1,701

1,244

608

397

391

394

194

109

27

12

Long-term investments

1,118

1,837

201

-

-

0

0

0

0

1,499

3,010

1,003

3,005

1,052

2,005

5,120

1,903

4,590

-

-

-

-

-

-

-

-

Operating lease right-of-use assets

2,833

3,001

1,500

1,692

1,763

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Other assets

64

64

65

63

70

70

53

53

53

49

49

49

46

46

30

30

30

30

30

30

22

22

22

-

-

0

Total assets

92,721

114,024

125,335

117,076

132,681

106,482

113,388

122,145

80,167

90,822

96,656

78,877

74,048

61,576

65,197

68,936

73,069

79,619

84,673

90,606

95,593

101,920

107,331

113,079

61,120

65,489

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

2,837

1,256

1,375

643

1,236

3,576

1,241

528

700

1,439

398

301

994

410

690

229

567

717

285

1,101

347

420

744

1,711

1,671

689

Accrued compensation

3,587

4,193

3,000

2,703

2,276

3,436

2,585

1,795

1,274

2,688

1,610

1,208

903

1,807

1,280

952

746

1,922

1,568

948

762

1,457

-

-

-

635

Accrued liabilities

3,153

4,131

5,007

3,558

7,071

8,169

5,032

3,951

1,925

1,900

1,627

1,012

950

1,650

677

508

582

569

1,120

782

1,045

975

1,635

1,684

958

886

Current portion of operating lease liabilities

618

644

730

734

708

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

10,195

10,224

10,112

7,638

11,291

15,181

8,858

6,274

3,899

6,027

3,635

2,521

2,847

3,867

2,647

1,689

1,895

3,208

2,973

2,831

2,154

2,852

2,379

-

-

2,210

Long-term operating lease liabilities

2,506

2,614

804

991

1,096

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred rent

-

-

0

-

-

94

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term loan payable, net of debt issuance costs

19,350

19,265

19,189

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liability

-

-

-

-

-

-

99

107

111

115

90

87

61

29

18

26

33

40

46

37

41

-

44

-

-

-

Long-term liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

-

-

-

0

Total liabilities

32,051

32,103

30,105

8,629

12,387

15,275

8,957

6,381

4,010

6,142

3,725

2,608

2,908

3,896

2,665

1,715

1,928

3,248

3,019

2,868

2,195

2,896

2,423

3,395

2,629

2,210

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Common stock, $0.0001 par value; 100,000,000 shares authorized; 39,289,624 and 39,203,533 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

4

4

4

4

4

3

3

3

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

Additional paid-in capital

306,482

304,963

302,533

300,462

298,028

252,885

250,670

248,978

198,147

196,688

195,194

170,655

158,763

138,810

137,810

136,795

135,783

135,021

133,830

132,824

131,610

130,521

129,579

128,307

68,990

67,610

Accumulated other comprehensive income (loss)

4

13

18

13

-13

-11

-13

-25

-42

-31

-16

-28

-32

-31

12

33

18

-50

4

-1

-10

-27

10

-14

-

0

Accumulated deficit

-245,820

-223,059

-207,325

-192,032

-177,725

-161,670

-146,229

-133,192

-121,951

-111,980

-102,250

-94,360

-87,593

-81,101

-75,292

-69,609

-64,662

-58,602

-52,182

-45,087

-38,204

-31,472

-24,683

-18,611

-10,501

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,333

Total stockholders' equity

60,670

81,921

95,230

108,447

120,294

91,207

104,431

115,764

76,157

84,680

92,931

76,269

71,140

57,680

62,532

67,221

71,141

76,371

81,654

87,738

93,398

99,024

104,908

109,684

58,491

63,279

Total liabilities and stockholders' equity

92,721

114,024

125,335

117,076

132,681

106,482

113,388

122,145

80,167

90,822

96,656

78,877

74,048

61,576

65,197

68,936

73,069

79,619

84,673

90,606

95,593

101,920

107,331

113,079

61,120

65,489